Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants'. The following are the other relevant details related to the trial:

Therapeutic Area: Immunology

Trial Centre(s): Lilly Centre for Pharmacology

Trial Status: NA

Principal Investigator(s): Dr Noel Mathew Varghese

Published by HT Digital Content Services with permission from Health Daily Digest....